Low raltegravir transfer into the breastmilk of a woman living with HIV

AIDS. 2020 Oct 1;34(12):1863-1865. doi: 10.1097/QAD.0000000000002624.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • HIV Integrase Inhibitors* / therapeutic use
  • Humans
  • Milk, Human
  • Pyrrolidinones / therapeutic use
  • Raltegravir Potassium / adverse effects
  • Raltegravir Potassium / analysis*

Substances

  • HIV Integrase Inhibitors
  • Pyrrolidinones
  • Raltegravir Potassium